Satellite Banner
Technology Networks Header
Monday, April 21, 2014
 
Register | Sign in
Home Page>Products
  Product News
BD Launches Innovative Diabetes Pen Needle
Thursday, March 27, 2014
BD Micro-Fine Ultra™ with Pentapoint 5-bevel technology helps to enhance patient comfort.

New Asia Tube Cooler from Syrris
Thursday, March 27, 2014
New module enables extra low temperature flow reactions.

New Open Access Platform Desktop Spotter To Be Unveiled At Analytica in Germany
Thursday, March 27, 2014
Poly-Pico Technologies Ltd. are showcasing their new open access platform desktop ‘Pico Spotter™’ at Analytica Munich in Germany next month.

EMD Millipore Launches New Kits for Use on Gyros’ Immunoassay Platform
Wednesday, March 26, 2014
Ready-to-use kits are fully qualified for reliable use in clinical research.

EKF Molecular Highlights Ultra-Sensitive Cancer Mutation Detection Kits
Wednesday, March 26, 2014
PointMan™ DNA-enrichment kits offer unrivalled cancer gene detection in whole blood.

Eliminate Tedious Sample Preparation with Laboratory Automation
Wednesday, March 26, 2014
Tecan offers laboratory automation solutions for MS sample preparation.

BioTek Presents Microplate-Based Workflow Solutions at Analytica 2014
Wednesday, March 26, 2014
Designed to automate and improve lab efficiency.

New Surface and Surface Interface Diagnostic Systems
Wednesday, March 26, 2014
Hiden’s new tools based on UHV Secondary Ion Mass Spectrometry technique.

WITec and TESCAN Product Launch at Analytica 2014
Wednesday, March 26, 2014
Both Companies launch new Correlative Raman Imaging and Scanning Electron Microscope.

<< 7 8 9 10 11 12 13 >>
Showing Results 91 - 100 of 10008
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv